IL22 and graft versus host disease: Indeed, IL-22 deficient mice undergone allo-HSCT suffer from severe intestinal GvHD and intestinal barrier disruption, while the administration of IL-22 in transplanted wild type animals limits the onset of intestinal GvHD and enhances both intestinal stem cell recovery and epithelial cell regeneration (91).